The new Kidney Care National Plan from the US Department of Health and Human Services focuses on preventing kidney failure, ...

The VOICE trial examined clinical outcomes and safety after administering vadadustat vs EPO during thrice-weekly hemodialysis ...

An investigator reported the results of a prespecified interim analysis of the phase 3 I CAN trial of ravulizumab for immunoglobulin A nephropathy.

Participants in the treatment group experienced a 93.5% reduction in urine soluble C5b9 levels from baseline to 24 months.

Telitacicept was associated with 6 times the odds of a decrease in proteinuria compared with immunosuppressive treatment at 48 weeks.

Living kidney donation is associated with a modestly increased risk of gestational hypertension, preeclampsia, or eclampsia. Women who become pregnant after donating a kidney face increased risks of ...

Keisha L. Gibson, MD, MPH, is a physician scientist and the division chief of Pediatric Nephrology department at UNC School ...

A bladder-sparing active surveillance program reported on outcomes in patients with muscle-invasive bladder cancer (MIBC).

The randomized VIDEO-KD trial tested the value of an ESKD video decision aid vs usual care for advanced care planning among older patients with advanced CKD.

Bodily pain, vitality, and general health perceptions showed stronger associations with quality of life at lower proteinuria thresholds.

Clinically approved drugs induced ChAT expression and acetylcholine production in podocytes in vivo, suggesting the pathway could be pharmacologically targeted.

An observational study found that living in neighborhoods with high urban heat intensity reduces the chances of textbook surgical recovery.